Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Valiant Organics Ltd (VALIANTORG)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540145 NSE: VALIANTORG Chemicals | Small Cap | Valiant Organics Share Price
₹453.05 -16.85 (-3.59%)
As on 13-Oct'26 10:41
Valiant Organics Ltd (VALIANTORG)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540145 NSE: VALIANTORG Chemicals | Small Cap | Valiant Organics Share Price
₹453.05 -16.85 (-3.59%)
As on 13-Oct'26 10:41
Key Metrics
Valuation Multiples
Market Cap
₹1,317 Cr.
Current Price
₹453.1
52-Week Low / High
₹195 / 508
TTM EPS
₹19.3
TTM Sales
₹766 Cr.
Book Value per Share
₹278.6
P/E Ratio
24.36
Higher than its 5-year historical median
Industry PE
47.6
Price to Book (P/B)
1.69
Higher than its 5-year historical median
Price to Sales (P/S)
1.72
Higher than its 5-year historical median
EV/EBITDA
13.76
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
4.48%
Underperforms industry median
Return on Capital Employed (ROCE)
6.05%
Underperforms industry median
Return on Assets (ROA)
2.75%
Operating Profit Margin
11.9%
Net Profit Margin
4.5%
Gross Profit Margin
10.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
2.73%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
63.45%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
37.87%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹753 Cr.
Equity
₹28 Cr.
Face Value
₹10
All Time Low / High
₹132.00 / 1925.50
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Strong
Is Valiant Organics Ltd a good quality company?
Valiant Organics Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Valiant Organics Ltd performance compare with that of its Peers?
Revenue growth of Valiant Organics Ltd vs industry peers?
Valiant Organics Ltd revenue CAGR is -0.43%, compared to the industry median CAGR of 0.00%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Valiant Organics Ltd?
Promoters hold 37.87% of the Valiant Organics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Valiant Organics Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -21.78% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Valiant Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 50.6% | 47.7% | 92.7% | 40.6% | 26.9% | 18.4% | 12.3% | 1.6% | 3% | 6.9% | - |
| Value Creation Index ⓘ | 2.6 | 2.4 | 5.6 | 1.9 | 0.9 | 0.3 | -0.1 | -0.9 | -0.8 | -0.5 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 73.4 | 121 | 606 | 584 | 574 | 948 | 912 | 677 | 719 | 738 | 766 |
| Sales YoY Gr. | - | 64.4% | 402.3% | -3.7% | -1.6% | 65.2% | -3.9% | -25.7% | 6.1% | 2.7% | - |
| Adj EPS ⓘ | 15.2 | 13.2 | 101.9 | 50 | 38.4 | 37.6 | 26.8 | -2.7 | -1.3 | 10.6 | 17.3 |
| YoY Gr. | - | -13.6% | 673.7% | -50.9% | -23.3% | -2% | -28.8% | -110% | NA | NA | - |
| BVPS (₹) ⓘ | 62.1 | 50.5 | 213.9 | 158.8 | 184.8 | 222 | 244.9 | 240.8 | 236.2 | 248.5 | 256.2 |
| Adj Net Profit ⓘ | 11.1 | 15.4 | 120 | 122 | 104 | 102 | 72.7 | -7.4 | -3.7 | 29.8 | 49 |
| Cash Flow from Ops. ⓘ | 9.5 | 17.8 | 77.1 | 160 | 115 | -11.2 | 183 | 85.1 | 58.6 | 44.3 | - |
| Debt/CF from Ops. ⓘ | 0.1 | 0 | 0.7 | 0.7 | 1.3 | -27.3 | 1.2 | 2.5 | 3.6 | 4.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 29.2% | 5.2% | -6.8% | 2.7% | ||||
| Adj EPS ⓘ | -3.9% | -22.7% | -26.5% | NA | ||||
| BVPSⓘ | 16.7% | 6.1% | 0.5% | 5.2% | ||||
| Share Price | - | -21.8% | -2.1% | 48.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 31.6 | 29 | 75 | 37.6 | 23.4 | 18.5 | 11.5 | -1.1 | -0.6 | 4.4 | 6.9 |
| Op. Profit Mgn % ⓘ | 25 | 21.9 | 29.6 | 29.8 | 27.4 | 17.5 | 14.4 | 5.8 | 7.5 | 12 | 13.7 |
| Net Profit Mgn % ⓘ | 15.1 | 12.8 | 19.7 | 20.8 | 18.2 | 10.8 | 8 | -1.1 | -0.5 | 4 | 6.4 |
| Debt to Equity ⓘ | 0 | 0 | 0.2 | 0.3 | 0.3 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | - |
| Working Cap Days ⓘ | 128 | 104 | 69 | 120 | 136 | 118 | 151 | 198 | 172 | 165 | 77 |
| Cash Conv. Cycle ⓘ | 39 | 24 | 22 | 30 | 25 | 49 | 68 | 70 | 51 | 74 | 3 |
Valuation of Valiant Organics - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.21 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 692 | 675 | 755 | 1,153 | 1,052 | 723 | 719 | 739 |
| Operating Expenses ⓘ + | 512 | 494 | 550 | 948 | 888 | 685 | 665 | 651 |
| Operating Profit ⓘ | 180 | 181 | 205 | 205 | 164 | 38 | 54 | 88 |
| Operating Profit Margin (%) | 26.0% | 26.7% | 27.2% | 17.8% | 15.6% | 5.2% | 7.5% | 11.9% |
| Other Income ⓘ + | 9 | 6 | 6 | 7 | 8 | 10 | 9 | 7 |
| Interest ⓘ | 4 | 3 | 5 | 6 | 11 | 16 | 24 | 18 |
| Depreciation ⓘ | 14 | 16 | 21 | 30 | 29 | 35 | 36 | 40 |
| Profit Before Tax ⓘ | 171 | 168 | 185 | 176 | 137 | -9 | 2 | 42 |
| Tax ⓘ | 50 | 42 | 54 | 48 | 35 | -0 | 6 | 9 |
| Profit After Tax | 121 | 126 | 131 | 128 | 103 | -8 | -3 | 33 |
| PAT Margin (%) | 17.5% | 18.7% | 17.3% | 11.1% | 9.8% | -1.2% | -0.5% | 4.5% |
| Adjusted EPS (₹) | 113.6 | 51.0 | 42.2 | 41.7 | 32.5 | -3.0 | -1.3 | 11.9 |
| Dividend Payout Ratio (%) | 5.30% | 10.80% | 11.90% | 8.40% | 3.10% | 0% | 0% | 0% |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 251 | 388 | 503 | 613 | 689 | 728 | 725 | 759 | |||
| Debt + | 77 | 125 | 185 | 328 | 229 | 222 | 227 | 222 | |||
| Minority Interest | 12 | 13 | 6 | 36 | 51 | 0 | 0 | -0 | |||
| Trade Payables | 74 | 88 | 107 | 131 | 166 | 207 | 149 | 122 | |||
| Others Liabilities ⓘ | 35 | 55 | 75 | 84 | 106 | 91 | 82 | 128 | |||
| Total Liabilities ⓘ | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,231 | |||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 150 | 276 | 510 | 543 | 670 | 643 | 657 | 695 | |||
| CWIP ⓘ | 66 | 129 | 46 | 112 | 71 | 86 | 66 | 21 | |||
| Investments ⓘ | 12 | 23 | 6 | 8 | 41 | 99 | 94 | 151 | |||
| Inventories | 48 | 45 | 72 | 114 | 126 | 114 | 89 | 92 | |||
| Trade Receivables | 141 | 133 | 157 | 321 | 254 | 209 | 177 | 243 | |||
| Cash Equivalents | 4 | 13 | 31 | 45 | 8 | 4 | 8 | 2 | |||
| Others Assets ⓘ | 28 | 51 | 54 | 49 | 68 | 93 | 93 | 27 | |||
| Total Assets ⓘ | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,231 | |||
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 76 | 161 | 115 | -31 | 238 | 84 | 56 | 92 |
| Cash Flow From Investing Activity ⓘ + | -88 | -184 | -159 | -124 | -143 | -65 | -21 | -86 |
| Cash Flow From Financing Activity ⓘ + | 1 | 27 | 49 | 167 | -112 | -23 | -32 | -11 |
| Net Cash Flow ⓘ | -11 | 5 | 5 | 12 | -17 | -4 | 4 | -5 |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 48.33 | 39.65 | 29.49 | 22.95 | 15.77 | -1.19 | -0.47 | 4.48 | ||
| ROCE (%) | 51.25 | 39.4 | 30.68 | 21.66 | 15.28 | 0.79 | 2.67 | 6.05 | ||
| Asset Turnover Ratio | 1.54 | 1.21 | 0.98 | 1.12 | 0.87 | 0.58 | 0.59 | 0.61 | ||
| PAT to CFO Conversion(x) | 0.63 | 1.28 | 0.88 | -0.24 | 2.31 | N/A | N/A | 2.79 | ||
| Working Capital Days | ||||||||||
| Receivable Days | 74.50 | 74.10 | 70 | 75.60 | 99.80 | 117 | 98.10 | 103.80 | ||
| Inventory Days | 25.30 | 25.10 | 28.30 | 29.40 | 41.60 | 60.70 | 51.60 | 44.60 | ||
| Payable Days | 68.90 | 75.30 | 88.50 | 57.10 | 79.90 | 143 | 142.20 | 113 | ||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Valiant Organics Ltd FAQs
The current trading price of Valiant Organics on 13-Oct-2026 10:41 is ₹453.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Oct-2026 the market cap of Valiant Organics stood at ₹1,317.4 Cr
The latest P/E ratio of Valiant Organics as of 12-Oct-2026 is 27.10.
The latest P/B ratio of Valiant Organics as of 12-Oct-2026 is 1.83.
The 52-week high of Valiant Organics is ₹507.9 and the 52-week low is ₹195.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Valiant Organics is ₹766 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Valiant Organics Ltd is a average quality company.
The key valuation ratios of Valiant Organics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Valiant Organics Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Valiant Organics Ltd
The company was incorporated as Valiant Organics Private Limited on February 16, 2005 under the Companies Act, 1956 and having its Registered Office in Mumbai, Maharashtra. Subsequently, the status of the company was changed to a public limited company and the name of the company was changed to Valiant Organics Limited vide special resolution dated November 26, 2014. A fresh Certificate of Incorporation consequent upon change of name was issued on July 31, 2015 by the Registrar of Companies, Mumbai in Maharashtra.
The company’s factory is well equipped with latest technology and advanced instruments in order to meet the international standards of quality which is well accepted not only by Indian customers, but also by its overseas customers in Europe, United States of America and Asia. It also offers customised specification of Chlorophenols as per the customer needs. The company’s manufacturing unit is strategically located at Sarigam in UmbergaonTaluka in Valsad District which is approximately at a distance of 180 kms from its main export port - NhavaSheva Port (JNPT) and approximately 155 kms from its office in Mumbai.
Over the years the company has built its goodwill amongst its customers and export markets and the demand for its products are more than its supply capacity, hence, it begun the process of applying with the government agencies to augment its production capacities upto 21,600 metric tonnes over the next few years in a phased manner. These expansion activities would be financed through its owned Net worth and internal accruals or certain amount of banking facilities or a combination of the same.It operates a single location manufacturing facility at Sarigam Industrial Estate having an installed capacity of 4,800 metric tonnes per annum.
Business area of the company
The company is a chemical manufacturing company with focus on manufacturing and marketing of different types of chlorophenol which is a chemical which has several applications mainly into agro-chemical industry, pharmaceutical industry, dyes industry, manufacturing of cosmetics and veterinary drugs.
Major Events
- 2005: Incorporation as Private Limited Company.
- 2005: Acquired assets and business of Valiant Chemical Corporation (partnership firm).
- 2008: Explored US overseas markets by commencing exports.
- 2013: Acquired additional plots, namely Plot No. 752, 753 and 754 at Sarigam.
- 2013: Increase in installed capacity from 3000 MTPA to 4800 MTPA.
- 2014: Explored Japan overseas markets by commencing exports.
- 2015: Converted into a Public Limited Company.
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
